MISSISSAUGA, Ontario--(BUSINESS WIRE)--Gilead Sciences Canada, Inc. (Gilead Canada) today announced that Health Canada has granted a Notice of Compliance (NOC) for DESCOVY® (emtricitabine 200 mg and ...
Gilead Sciences, after striking a similar deal in 2014 to delay generics of its earlier HIV pre-exposure prophylaxis (PrEP) med Truvada, has followed suit on its key next-gen offering Descovy. Monday, ...
In a move that is expected to prove transformative to the national HIV-prevention effort, the federal government has announced that almost all health insurers must cover the HIV prevention pill, known ...
Descovy is a medication used to treat HIV. It is also prescribed as PrEP (preexposure prophylaxis) to prevent HIV infection in individuals who are at risk of HIV. When used as HIV treatment, Descovy ...
May 9 (Reuters) - A federal jury on Tuesday found that Gilead Sciences Inc GILD.O did not infringe U.S. patents with its HIV-prevention regimens using the drugs Truvada and Descovy, handing the ...
The federal government announced that all health insurance providers should offer Truvada or Descovy, the two drugs approved for HIV prevention, free. Currently, Descovy is the preferred drug and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results